A Phase 2 Clinical Trial to Evaluate Efficacy, Safety, and Tolerability of Navepegritide in Combination With Lonapegsomatropin in Children With Achondroplasia
Clinical trial NCT06433557 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06433557
- Sponsor
- Ascendis Pharma Growth Disorders A/S
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-26
- Primary completion
- 2025-11-14
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.